You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 康寧傑瑞-B(9966.HK)大漲10% 藥物產品管線及業務經營方面取得重大進展
格隆匯 08-30 15:20
格隆匯8月30日丨康寧傑瑞-B(9966.HK)大幅拉昇漲10%,報19.64港元,成交額達1.1億港元,總市值184億港元。上半年公司研發開支同比增加73.5%至2.32億元。自2021年4月20日(即公司2020年年報的最後可行日期)以來,公司在藥物產品管線及業務經營方面取得了重大進展,其中,KN046已在澳大利亞完成I期臨牀試驗,且同時在美國開展一項II期臨牀試驗。此外,公司打算繼續擴大公司的團隊以期望推出更多的產品及獲批更多的適應症。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account